Mitochondrial genetics

British Medical Bulletin

Volumn 106, Issue 1, 2013, Pages 135-159

  Chinnery, Patrick Francis ^a   Hudson, Gavin ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

genetics; mitochondria; mitochondrial disease; mitochondrial DNA; mtDNA

Indexed keywords

MITOCHONDRIAL DNA; DNA DIRECTED DNA POLYMERASE GAMMA; DYNAMIN I; MITOFUSIN 1; MITOFUSIN 2;

CELL ENERGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA TRANSCRIPTION; GENETIC DISORDER; HETEROPLASMY; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MELAS SYNDROME; MITOCHONDRIAL DNA REPLICATION; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL GENETICS; MITOCHONDRION; PRIORITY JOURNAL; REVIEW; ARTICLE; COMPLEX I DEFICIENCY; COMPLEX III DEFICIENCY; DNA STRUCTURE; FAMILY HISTORY; GENETIC MANIPULATION; INHERITANCE; MEDLINE; MITOCHONDRIAL GENOME; SEQUENCE HOMOLOGY;

GENETICS; MITOCHONDRIA; MITOCHONDRIAL DISEASE; MITOCHONDRIAL DNA; MTDNA;

DATABASES, NUCLEIC ACID; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION;

EID: 84878888076     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldt017     Document Type: Review

References (167)

1. van der Giezen M, Tovar J. Degenerate mitochondria. EMBO Rep 2005;6:525-30.
2. Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 2012;13:878-90.
3. Schapira AH. Mitochondrial diseases. Lancet 2012;379:1825-34.
4. Koopman WJ, Distelmaier F, Smeitink JA et al. OXPHOS mutations and neurodegeneration. EMBO J 2013;32:9-29.
5. Andrews RM, Kubacka I, Chinnery PF et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999;23:147.
6. Temperley R, Richter R, Dennerlein S et al. Hungry codons promote frameshifting in human mitochondrial ribosomes. Science 2010;327:301.
7. Sutovsky P. Ubiquitin-dependent proteolysis in mammalian spermatogenesis, fertilization, and sperm quality control: killing three birds with one stone. Microsc Res Tech 2003;61:88-102.
8. Vissing JSaM. Paternal Inheritance if mitochondrial DNA. N Engl J Med 2002;2081-2.
9. Miller FJ, Rosenfeldt FL, Zhang C et al. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucleic Acids Res 2003;31:e61.
10. Birky CW Jr. The inheritance of genes in mitochondria and chloroplasts: laws, mechanisms, and models. Annu Rev Genet 2001;35:125-48.
11. Payne BA, Wilson IJ, Yu-Wai-Man P et al. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet 2013;22:384-90.
12. Calvo S, Jain M, Xie X et al. Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 2006;38:576-82.
13. Hirst J. Why does mitochondrial complex I have so many subunits Biochem J 2011;437:e1-3.
14. Angerer H, Zwicker K, Wumaier Z et al. A scaffold of accessory subunits links the peripheral arm and the distal proton-pumping module of mitochondrial complex I. Biochem J 2011;437:279-88.
15. Smith PM, Fox JL, Winge DR. Biogenesis of the cytochrome bc(1) complex and role of assembly factors. Biochim Biophys Acta 2012;1817:276-86.
16. Vogel RO, Smeitink JA, Nijtmans LG. Human mitochondrial complex I assembly: a dynamic and versatile process. Biochim Biophys Acta 2007;1767:1215-27.
17. Mick DU, Fox TD, Rehling P. Inventory control: cytochrome c oxidase assembly regulates mitochondrial translation. Nat Rev Mol Cell Biol 2011;12:14-20.
18. Wang ZG, White PS, Ackerman SH. Atp11p and Atp12p are assembly factors for the F (1)-ATPase in human mitochondria. J Biol Chem 2001;276:30773-8.
19. Copeland WC. Defects in mitochondrial DNA replication and human disease. Crit Rev Biochem Mol Biol 2012;47:64-74.
20. Bogenhagen DF. Mitochondrial DNA nucleoid structure. Biochim Biophys Acta 2012;1819:914-20.
21. Kukat C, Wurm CA, Spahr H et al. Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA. Proc Natl Acad Sci USA 2011;108:13534-9.
22. McCulloch V, Seidel-Rogol BL, Shadel GS. A human mitochondrial transcription factor is related to RNA adenine methyltransferases and binds S-adenosylmethionine. Mol Cell Biol 2002;22:1116-25.
23. McCulloch V, Shadel GS. Human mitochondrial transcription factor B1 interacts with the C-terminal activation region of h-mtTFA and stimulates transcription independently of its RNA methyltransferase activity. Mol Cell Biol 2003;23:5816-24.
24. Metodiev MD, Lesko N, Park CB et al. Methylation of 12S rRNA is necessary for in vivo stability of the small subunit of the mammalian mitochondrial ribosome. Cell Metab 2009;9:386-97.
25. Gaspari M, Larsson NG, Gustafsson CM. The transcription machinery in mammalian mitochondria. Biochim Biophys Acta 2004;1659:148-52.
26. Ma J, Farwell MA, Burkhart WA et al. Cloning and sequence analysis of the cDNA for bovine mitochondrial translational initiation factor 2. Biochim Biophys Acta 1995;1261:321-4.
27. Koc EC, Spremulli LL. Identification of mammalian mitochondrial translational initiation factor 3 and examination of its role in initiation complex formation with natural mRNAs. J Biol Chem 2002;277:35541-9.
28. Christian B, Haque E, Spremulli L. Ribosome shifting or splitting: it is all up to the EF-G. Mol Cell 2009;35:400-2.
29. Hammarsund M, Wilson W, Corcoran M et al. Identification and characterization of two novel human mitochondrial elongation factor genes, hEFG2 and hEFG1, phylogenetically conserved through evolution. Hum Genet 2001;109:542-50.
30. Ling M, Merante F, Chen HS et al. The human mitochondrial elongation factor tu (EF-Tu) gene: cDNA sequence, genomic localization, genomic structure, and identification of a pseudogene. Gene 1997;197:325-36.
31. Smits P, Smeitink J, van den Heuvel L. Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010;2010:737385.
32. Zhang Y, Spremulli LL. Identification and cloning of human mitochondrial translational release factor 1 and the ribosome recycling factor. Biochim Biophys Acta 1998;1443:245-50.
33. Soleimanpour-Lichaei HR, Kuhl I, Gaisne M et al. mtRF1a is a human mitochondrial translation release factor decoding the major termination codons UAA and UAG. Mol Cell 2007;27:745-57.
34. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012;337:1062-5.
35. Schaefer AM, McFarland R, Blakely EL et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008;63:35-9.
36. Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 2003;126(Pt 8):1905-12.
37. Majamaa K, Moilanen JS, Uimonen S et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998;63:447-54.
38. Darin N, Oldfors A, Moslemi AR et al. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol 2001;49:377-83.
39. Magner M, Szentivanyi K, Svandova I et al. Elevated CSF-lactate is a reliable marker of mitochondrial disorders in children even after brief seizures. Eur J Paediatr Neurol 2011;15:101-8.
40. Barkovich AJ, Good WV, Koch TK et al. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993;14:1119-37.
41. Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 2003;24:33-41.
42. Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 2000;355:299-304.
43. Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 2000;355:389-94.
44. Rahman S, Poulton J, Marchington D et al. Decrease of 3243 A-G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet 2001;68:238-40.
45. Harman D. The biologic clock: the mitochondria J Am Geriatr Soc 1972;20:145-7.
46. Hegde ML, Mantha AK, Hazra TK et al. Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases. Mech Ageing Dev 2012;133:157-68.
47. Howell N. Origin, cellular expression, and cybrid transmission of mitochondrial CAP-R, PYR-IND, and OLI-R mutant phenotypes. Somat Cell Genet 1983;9:1-24.
48. Chinnery PF, Howell N, Lightowlers RN et al. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 1997;120: 1713-21.
49. White SL, Collins VR, Wolfe R et al. Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. Am J Hum Genet 1999;65:474-82.
50. Weber K,Wilson JN, Taylor L et al. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet 1997;60:373-80.
51. Poulton J, O'Rahilly S, Morten KJ et al. Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome. Diabetologia 1995;38:868-71.
52. Torroni A, Huoponen K, Francalacci P et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 1996;144:1835-50.
53. Pello R, Martin MA, Carelli V et al. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum Mol Genet 2008;17:4001-11.
54. Pyle A, Foltynie T, Tiangyou W et al. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 2005;57:564-7.
55. Santoro A, Balbi V, Balducci E et al. Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS One 2010;5:e12037.
56. Ridge PG, Maxwell TJ, Corcoran CD et al. Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging. PLoS One 2012;7:e45134.
57. Udar N, Atilano SR, Memarzadeh M et al. Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:2966-74.
58. Chinnery PF, Elliott HR, Hudson G et al. Epigenetics, epidemiology and mitochondrial DNA diseases. Int J Epidemiol 2012;41:177-87.
59. Ghezzi D, Zeviani M. Assembly factors of human mitochondrial respiratory chain complexes: physiology and pathophysiology. Adv Exp Med Biol 2012;748:65-106.
60. MITOMAP. A human mitochondrial genome database, 2000. http://www.gen.emory.edu/mitomap.html.
61. Rossignol R, Faustin B, Rocher C et al. Mitochondrial threshold effects. Biochem J 2003;370 (Pt 3):751-62.
62. Schon EA, Rizzuto R, Moraes CT et al. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 1989;244:346-9.
63. Krishnan KJ, Reeve AK, Samuels DC et al. What causes mitochondrial DNA deletions in human cells Nat Genet 2008;40:275-9.
64. Wallace DC, Singh G, Lott MT et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-30.
65. Carelli V, Ghelli A, Ratta M et al. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology 1997;48:1623-32.
66. Carelli V, La Morgia C, Valentino ML et al. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim Biophys Acta 2009;1787:518-28.
67. Hudson G, Keers S, YuWai Man P et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet 2005;77:1086-91.
68. Achilli A, Iommarini L, Olivieri A et al. Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber's hereditary optic neuropathy. PLoS One 2012;7: e42242.
69. Kirkman MA, Yu-Wai-Man P, Korsten A et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009;132(Pt 9):2317-26.
70. Hudson G, Carelli V, Spruijt L et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 2007;81:228-33.
71. Carvalho MR, Muller B, Rotzer E et al. Leber's hereditary optic neuroretinopathy and the X-chromosomal susceptability factor: no linkage to DXS7. Hum Hered 1992;42:316-20.
72. Chen JD, Cox I, Denton MJ. Prelimanary exclusion of an X-linked gene in Leber optic atrophy by linkage analysis. Hum Genet 1989;82:302-7.
73. Abu-Amero K, Jaber M, Hellani A et al. Genome-wide expression profile of LHON patients with the 11778 mutation. Br J Ophthalmol (2009/09/04 ed), 2009.
74. Phasukkijwatana N, Kunhapan B, Stankovich J et al. Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand. Hum Genet (2010/04/22 ed).
75. Prezant TR, Agapian JV, Bohlman MC et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993;4: 289-94.
76. Zifa E, Giannouli S, Theotokis P et al. Mitochondrial tRNA mutations: clinical and functional perturbations. RNA Biol 2007;4:38-66.
77. McFarland R, Elson JL, Taylor RW et al. Assigning pathogenicity to mitochondrial tRNA mutations: when 'definitely maybe' is not good enough. Trends Genet 2004;20:591-6.
78. Pavlakis SG, Phillips PC, DiMauro S et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-8.
79. Hirano M, Ricci E, Koenigsberger MR et al. Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992;2:125-35.
80. Manwaring N, Jones MM,Wang JJ et al. Population prevalence of the MELAS A3243G mutation. Mitochondrion 2007;7:230-3.
81. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-3.
82. Santorelli FM, Tanji K, Kulikova R et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 1997;238:326-8.
83. Shoffner JM, Lott MT, Lezza AM et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990;61:931-7.
84. Zeviani M, Moraes CT, DiMauro S et al. Deletions of mitochondrial DNA in Kearns-Sayre syndorme. Neurology 1988;38:1339-46.
85. Moraes CT, DiMauro S, ZevianiMet al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-9.
86. Rotig A, Cormier V, Blanche S et al. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990;86:1601-8.
87. Horvath R, Hudson G, Ferrari G et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006;129(Pt 7):1674-84.
88. Spelbrink JN, Li FY, Tiranti V et al. Human mitochondrial DNA deletios associated with mutations in the gene encoding Twinkle, a phage T7 gene4-like protein localized in mitochondria. Nat Genet 2001;28:223-31.
89. Agostino A, Valletta L, Chinnery PF et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003;60:1354-6.
90. Wolf A, Cowen D. The cerebral atrophies and encephalomalacias of infancy and childhood. Res Publ Assoc Res Nerv Ment Dis 1955;34:199-330.
91. Kollberg G, Moslemi AR, Darin N et al. POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol 2006;65:758-68.
92. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004;55:706-12.
93. Clayton DA. Replication of animal mitochondrial DNA. Cell 1982;28:693-705.
94. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic communication. Biosci Rep 2007;27:39-51.
95. Haack TB, Haberberger B, Frisch EM et al. Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing. J Med Genet 2012;49:277-83.
96. Loeffen JL, Smeitink JA, Trijbels JM et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 2000;15:123-34.
97. Lebre AS, Rio M, Faivre d'Arcier L et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet 2011;48:16-23.
98. Benit P, Chretien D, Kadhom N et al. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 2001;68:1344-52.
99. Benit P, Slama A, Cartault F et al. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J Med Genet 2004;41:14-7.
100. van den Heuvel L, RuitenbeekW, Smeets R et al. Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 1998;62:262-8.
101. Smeitink J, van den Heuvel L. Human mitochondrial complex I in health and disease. Am J Hum Genet 1999;64:1505-10.
102. Loeffen J, Smeitink J, Triepels R et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998;63:1598-608.
103. Schuelke M, Smeitink J, Mariman E et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 1999;21:260-1.
104. Hoefs SJ, van Spronsen FJ, Lenssen EW et al. NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease. Eur J Hum Genet 2011;19:270-4.
105. Hoefs SJ, Dieteren CE, Distelmaier F et al. NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 2008;82:1306-15.
106. Shoubridge EA. Nuclear genetic defects of oxidative phosphorylation. Hum Mol Genet 2001;10:2277-84.
107. Loeffen J, Elpeleg O, Smeitink J et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 2001;49:195-201.
108. Kirby DM, Salemi R, Sugiana C et al. NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 2004;114:837-45.
109. Benit P, Beugnot R, Chretien D et al. Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat 2003;21:582-6.
110. Berger I, Hershkovitz E, Shaag A et al. Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation. Ann Neurol 2008;63:405-8.
111. Haack TB, Danhauser K, Haberberger B et al. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 2010;42:1131-4.
112. Calvo SE, Tucker EJ, Compton AG et al. High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat Genet 2010;42: 851-8.
113. Gerards M, Sluiter W, van den Bosch BJ et al. Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome. J Med Genet 2010;47:507-12.
114. Saada A, Edvardson S, Rapoport M et al. C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet 2008;82:32-8.
115. Dunning CJ, McKenzie M, Sugiana C et al. Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. EMBO J 2007;26: 3227-37.
116. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39: 617-22.
117. Petruzzella V, Tiranti V, Fernandez P et al. Identification and characterization of human cDNAs specific to BCS1, PET112, SCO1, COX15, and COX11, five genes involved in the formation and function of the mitochondrial respiratory chain. Genomics 1998;54:494-504.
118. de Lonlay P, Valnot I, Barrientos A et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 2001;29:57-60.
119. Haut S, Brivet M, Touati G et al. A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum Genet 2003;113:118-22.
120. Barel O, Shorer Z, Flusser H et al. Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ. Am J Hum Genet 2008;82:1211-6.
121. Ghezzi D, Arzuffi P, Zordan M et al. Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies. Nat Genet 2011;43:259-63.
122. Massa V, Fernandez-Vizarra E, Alshahwan S et al. Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet 2008;82:1281-9.
123. Antonicka H, Leary SC, Guercin GH et al. Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum Mol Genet 2003;12:2693-702.
124. Coenen MJ, van den Heuvel LP, Ugalde C et al. Cytochrome c oxidase biogenesis in a patient with a mutation in COX10 gene. Ann Neurol 2004;56:560-4.
125. Indrieri A, van Rahden VA, Tiranti V et al. Mutations in COX7B cause microphthalmia with linear skin lesions, an unconventional mitochondrial disease. Am J Hum Genet 2012;91:942-9.
126. Zvulunov A, Kachko L, Manor E et al. Reticulolinear aplasia cutis congenita of the face and neck: a distinctive cutaneous manifestation in several syndromes linked to Xp22. Br J Dermatol 1998;138:1046-52.
127. Shteyer E, Saada A, Shaag A et al. Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene. Am J Hum Genet 2009;84:412-7.
128. Zhu Z, Yao J, Johns T et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998;20:337-43.
129. Tiranti V, Jaksch M, Hofmann S et al. Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Ann Neurol 1999;46:161-6.
130. WeraarpachaiW, Sasarman F, Nishimura T et al. Mutations in C12orf62, a factor that couples COX I synthesis with cytochrome c oxidase assembly, cause fatal neonatal lactic acidosis. Am J Hum Genet 2012;90:142-51.
131. Huigsloot M, Nijtmans LG, Szklarczyk R et al. A mutation in C2orf64 causes impaired cytochrome c oxidase assembly and mitochondrial cardiomyopathy. Am J Hum Genet 2011;88:488-93.
132. Ghezzi D, Saada A, D'Adamo P et al. FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency. Am J Hum Genet 2008;83:415-23.
133. Mayr JA, Havlickova V, Zimmermann F et al. Mitochondrial ATP synthase deficiency due to a mutation in the ATP5E gene for the F1 epsilon subunit. Hum Mol Genet 2010;19:3430-9.
134. De Meirleir L, Seneca S, LissensWet al. Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J Med Genet 2004;41:120-4.
135. Saada A, Shaag A, Arnon S et al. Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J Med Genet 2007;44:784-6.
136. Zeharia A, Fischel-Ghodsian N, Casas K et al. Mitochondrial myopathy, sideroblastic anemia, and lactic acidosis: an autosomal recessive syndrome in Persian Jews caused by a mutation in the PUS1 gene. J Child Neurol 2005;20:449-52.
137. Smirnova E, Shurland DL, Ryazantsev SN et al. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 1998;143:351-8.
138. Waterham HR, Koster J, van Roermund CWet al. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007;356:1736-41.
139. Cree LM, Samuels DC, de Sousa Lopes SC et al. A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. Nat Genet 2008;40:249-54.
140. Carling PJ, Cree LM, Chinnery PF. The implications of mitochondrial DNA copy number regulation during embryogenesis. Mitochondrion 2011;11:686-92.
141. DiMauro S, Schon EA. Mitochondrial DNA mutations in human disease. Am J Med Genet 2001;106:18-26.
142. Clark MJ, Chen R, Lam HY et al. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 2011;29:908-14.
143. McCormick E, Place E, Falk MJ. Molecular Genetic Testing for Mitochondrial Disease: From One Generation to the Next. Neurotherapeutics 2013;10:251-61.
144. Pagliarini DJ, Calvo SE, Chang B et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008;134:112-23.
145. Prokisch H, Andreoli C, Ahting U et al. MitoP2: the mitochondrial proteome database-now including mouse data. Nucleic Acids Res 2006;34(database issue):D705-11.
146. Pierson TM, Adams D, Bonn F et al. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet 2011;7:e1002325.
147. Vedrenne V, Gowher A, De Lonlay P et al. Mutation in PNPT1, which encodes a polyribonucleotide nucleotidyltransferase, impairs RNA import into mitochondria and causes respiratorychain deficiency. Am J Hum Genet 2012;91:912-8.
148. Janer A, Antonicka H, Lalonde E et al. An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. Am J Hum Genet 2012;91:737-43.
149. Casey JP, McGettigan P, Lynam-Lennon N et al. Identification of a mutation in LARS as a novel cause of infantile hepatopathy. Mol Genet Metab 2012;106:351-8.
150. Galmiche L, Serre V, Beinat M et al. Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy. Hum Mutat 2011;32:1225-31.
151. Gotz A, Tyynismaa H, Euro L et al. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 2011;88:635-42.
152. Pfeffer G, Elliott HR, Griffin H et al. Titin mutation segregates with hereditary myopathy with early respiratory failure. Brain 2012;135(Pt 6):1695-713.
153. Chinnery PF, Thorburn DR, Samuels DC et al. The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both Trends Genet 2000;16:500-5.
154. Monnot S, Gigarel N, Samuels DC et al. Segregation of mtDNA throughout human embryofetal development: m.3243AG as a model system. Hum Mutat 2011;32:116-25.
155. Pfeffer G, Majamaa K, Turnbull DM et al. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2012;4:CD004426.
156. Klopstock T, Yu-Wai-Man P, Dimitriadis K et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 2011;134:2677-86.
157. Kyriakouli DS, Boesch P, Taylor RW et al. Progress and prospects: gene therapy for mitochondrial DNA disease. Gene Ther 2008;15:1017-23.
158. Nagley P, Farrell LB, Gearing DP et al. Assembly of functional proton-translocating ATPase complex in yeast mitochondria with cytoplasmically synthesized subunit 8, a polypeptide normally encoded within the organelle. Proc Natl Acad Sci USA 1988;85:2091-5.
159. Bonnet C, Kaltimbacher V, Ellouze S et al. Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complex I or v subunits. Rejuvenation Res 2007;10:127-44.
160. Taivassalo T, Gardner JL, Taylor RW et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 2006;129(Pt 12): 3391-401.
161. Halter J, Schupbach WM, Casali C et al. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2011;46:330-7.
162. Wong LJ, Brunetti-Pierri N, Zhang Q et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 2007;46:1218-27.
163. Hellebrekers DM, Wolfe R, Hendrickx AT et al. PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring. Hum Reprod Update 2012;18:341-9.
164. Thorburn D, Wilton L, Stock-Myer S. Healthy baby girl born following pre-implantation Genetic diagnosis for mitochondrial DNA m.8993tg Mutation. Mol Genet Metab 2009;98:5-6.
165. Craven L, Tuppen HA, Greggains GD et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010;465:82-5.
166. Tachibana M, Amato P, Sparman M et al. Towards germline gene therapy of inherited mitochondrial diseases. Nature 2013;493:627-31.
167. Poulton J, Oakeshott P. Nuclear transfer to prevent maternal transmission of mitochondrial DNA disease. BMJ 2012;345:e6651.